The potential for misusing “genetic predisposition” in Canadian courts and tribunals - 06/10/11
Doi : 10.1503/cmaj.110260
Roxanne Mykitiuk, LLB SJD a, Mark Pioro, MA JD c, Lilith Finkler, PhD c, Jeff Nisker, MD PhD b, ⁎ 
a Roxanne Mykitiuk is with Osgoode Hall Law School, York University, Toronto, Ont.
b Jeff Nisker is with the Schulich School of Medicine and Dentistry, the University of Western Ontario, London Health Sciences Centre, London, Ont.
c At the time this analysis was conducted, Mark Pioro and Lilith Finkler were research associates with Osgoode Hall Law School, York University, Toronto, Ont.
* Correspondence to: Dr. Jeff Nisker
Contributors: Roxanne Mykitiuk and Jeff Nisker conceived of this article. All of the authors helped draft the aritcle, revised it critically for important intellectual content and approved the final version submited for publication.
Mappa
| Competing interests: The insititutions for which Roxanne Mykitiuk, Jeffrey Nisker and Mark Pioro work have received grants and financial support from Genome Canada. No other competing interests were declared. This article has been peer reviewed. Funding: This analysis was funded by Genome Canada and the Ontario Genomics Institute. |
© 2011
Canadian Medical Association. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 183 - N° 14
P. 1601-1604 - ottobre 2011 Ritorno al numero
Articolo precedente
- Predictors of survival after cardiac or respiratory arrest in critical care units
- Demetrios J. Kutsogiannis, Sean M. Bagshaw, Bryce Laing, Peter G. Brindley
- Clinical shorts
- Diane Kelsall
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?